Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

May 20, 2024

Study Completion Date

August 30, 2024

Conditions

BPH with Other Lower Urinary Tract Symptoms

Interventions

DRUG

Tamsulosin 0.4 mg

administered tamsulosin 0.4 mg

DRUG

Tadalafil 5mg

administered tadalafil 5 mg

DRUG

Tamsulosin and Tadalafil

administered tamsulosin 0.4 mg plus tadalafil 5 mg

Trial Locations (1)

Mohamed Mahmoud Dogha, Al Fayyum

All Listed Sponsors

lead

Fayoum University Hospital

OTHER